Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation.
about
Induction of MAPK- and ROS-dependent autophagy and apoptosis in gastric carcinoma by combination of romidepsin and bortezomibSmall molecule perturbation of the CAND1-Cullin1-ubiquitin cycle stabilizes p53 and triggers Epstein-Barr virus reactivation.Pathogenic Role of Exosomes in Epstein-Barr Virus (EBV)-Associated Cancers.Antitumor effects of duvelisib on Epstein-Barr virus-associated lymphoma cells.
P2860
Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeted therapy for Epstein-B ...... bine-induced lytic activation.
@ast
Targeted therapy for Epstein-B ...... bine-induced lytic activation.
@en
type
label
Targeted therapy for Epstein-B ...... bine-induced lytic activation.
@ast
Targeted therapy for Epstein-B ...... bine-induced lytic activation.
@en
prefLabel
Targeted therapy for Epstein-B ...... bine-induced lytic activation.
@ast
Targeted therapy for Epstein-B ...... bine-induced lytic activation.
@en
P2093
P2860
P356
P1433
P1476
Targeted therapy for Epstein-B ...... bine-induced lytic activation.
@en
P2093
Curtis R Chong
Eun Jung Kim
Hyun Gyu Lee
Hyunki Kim
Jae Myun Lee
Jeon Han Park
Jianmeng Chen
Pil-Gu Park
P2860
P304
31018-31029
P356
10.18632/ONCOTARGET.5041
P407
P577
2015-09-04T00:00:00Z